Scotiabank Has Negative Estimate for TSE:ATR FY2027 Earnings

SNC-Lavalin Group Inc. (TSE:ATR) – Scotiabank reduced their FY2027 earnings per share estimates for shares of SNC-Lavalin Group in a note issued to investors on Wednesday, July 15th. Scotiabank analyst J. Goldman now anticipates that the company will earn $4.32 per share for the year, down from their prior estimate of $4.39.

SNC-Lavalin Group Price Performance

SNC-Lavalin Group Company Profile

AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.